Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M van Praag

Showing results (231-240 of 290) with videos related to

Pageof 29
Sort By:
Archives of General Psychiatry|March 1, 1979
Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE)W M Verhoeven, H M van Praag, J M van Ree, et al.
Lancet (London, England)|March 17, 1973
Clinical significance of probenecid testJ P Lakke, J Korf, H M van Praag, et al.
Psychopharmacology|January 1, 1992
A dose-response study of intravenous m-chlorophenylpiperazine in normal subjectsO Kalus, S Wetzler, R S Kahn, et al.
Biological Psychiatry|January 15, 1988
Serotonin and anxiety revisitedR S Kahn, H M van Praag, S Wetzler, et al.
Biological Psychiatry|December 15, 1990
Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacksO Kalus, R S Kahn, S Wetzler, et al.
Psychopharmacology|February 23, 1999
Specificity of the tryptophan depletion methodT Klaassen, W J Riedel, N E Deutz, et al.
Biological Psychiatry|February 1, 1987
Therapeutic indications for serotonin-potentiating compounds: a hypothesisH M van Praag, R Kahn, G M Asnis, et al.
Psychiatry Research|July 1, 1992
Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjectsG M Asnis, S Wetzler, W C Sanderson, et al.
Psychopharmacology|March 25, 1999
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidationW J Riedel, T Klaassen, N E Deutz, et al.
The American Journal of Psychiatry|March 1, 1992
High cholesterol levels in patients with panic disorderW K Bajwa, G M Asnis, W C Sanderson, et al.
Pageof 29

Showing results (231-240 of 290) with videos related to

Sort By:
Pageof 29
Archives of General Psychiatry|March 1, 1979
Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE)W M Verhoeven, H M van Praag, J M van Ree, et al.
Lancet (London, England)|March 17, 1973
Clinical significance of probenecid testJ P Lakke, J Korf, H M van Praag, et al.
Psychopharmacology|January 1, 1992
A dose-response study of intravenous m-chlorophenylpiperazine in normal subjectsO Kalus, S Wetzler, R S Kahn, et al.
Biological Psychiatry|January 15, 1988
Serotonin and anxiety revisitedR S Kahn, H M van Praag, S Wetzler, et al.
Biological Psychiatry|December 15, 1990
Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacksO Kalus, R S Kahn, S Wetzler, et al.
Psychopharmacology|February 23, 1999
Specificity of the tryptophan depletion methodT Klaassen, W J Riedel, N E Deutz, et al.
Biological Psychiatry|February 1, 1987
Therapeutic indications for serotonin-potentiating compounds: a hypothesisH M van Praag, R Kahn, G M Asnis, et al.
Psychiatry Research|July 1, 1992
Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjectsG M Asnis, S Wetzler, W C Sanderson, et al.
Psychopharmacology|March 25, 1999
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidationW J Riedel, T Klaassen, N E Deutz, et al.
The American Journal of Psychiatry|March 1, 1992
High cholesterol levels in patients with panic disorderW K Bajwa, G M Asnis, W C Sanderson, et al.
Pageof 29